This effect was consistent when subgrouping for cancer type, as ANGPTL4 was linked to worse overall survival in breast cancer, gastrointestinal cancers, and oral cancers, despite not reaching statistical significance in the latter two. This evidence concerns the gene ANGPTL4 and lip and oral cavity carcinoma.